Experimental and Clinical Endocrinology & Diabetes, Inhaltsverzeichnis Exp Clin Endocrinol Diabetes 2023; 131(06): 375-376DOI: 10.1055/a-2075-0735 Letter to the Editor The Prevalence of Primary Aldosteronism in Screening Populations: Is Hypokalaemia Important? David M Williams 1 Department of Diabetes and Endocrinology, Morriston Hospital, Swansea, SA6 6NL , Ayesha Shaikh 1 Department of Diabetes and Endocrinology, Morriston Hospital, Swansea, SA6 6NL , Ellen Williams 2 Department of Acute Medicine, Morriston Hospital, Swansea, SA6 6NL , Aiman Maroof 2 Department of Acute Medicine, Morriston Hospital, Swansea, SA6 6NL , Therese Michael 3 Department of Laboratory Medicine, Morriston Hospital, Swansea, SA6 6NL , Kusuma Boregowda 1 Department of Diabetes and Endocrinology, Morriston Hospital, Swansea, SA6 6NL› InstitutsangabenArtikel empfehlen Abstract Artikel einzeln kaufenKey words Key wordsprimary aldosteronism - hypokalaemia screening Volltext Referenzen References 1 Asbach E, Kellnar A, Bekeran M. et al. Prevalence of primary aldosteronism in newly diagnosed hypertensive patients in primary care. Exp Clin Endocrinol Diabetes 2022; 130: 801-805 2 Funder JW, Carey RM, Mantero F. et al. The management of primary aldosteronism: Case detection, diagnosis, and treatment: An Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab 2016; 101: 1889-1916 3 Lonati C, Bassani N, Gritti A. et al. Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension. J Hypertens 2014; 32: 627-634 4 Buffolo F, Monticone S, Burrello J. et al. Is primary aldosteronism still largely unrecognized?. Horm Metab Res 2017; 49: 908-914
